Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence of Antibodies After Vaccination With GSK Biologicals' Meningococcal Vaccine GSK134612 in Adolescents and Young Adults

NCT00974363 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00974363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00974363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence of Antibodies After Vaccination With GSK Biologicals' Meningococcal Vaccine GSK134612 in Adolescents and Young Adults
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
May 31, 2013
Enrollment
697 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

infections, meningococcal